Private

Gates Foundation pledges up to $120M to spur access to COVID-19 drug molnupiravir for low-income countries

Recognizing the delays that have plagued low-income countries at nearly every aspect of the COVID-19 pandemic, the Bill & Melinda…

2 days ago

Phase 3 results of Valneva COVID-19 vaccine candidate show high antibody response, tolerability

Results arrived this week for a Phase 3 trial of Valneva SE’s COVID-19 vaccine candidate, VLA2001, and they revealed neutralizing…

3 days ago

Lockheed Martin secures Army tactical vehicle contract

Lockheed Martin has secured a $9,672,781 Army Project Agreement to continue developing the Terrestrial Layer System (TLS) program for the…

4 days ago

NIH RADx initiative awards $77.7 million for rapid COVID-19 diagnostics tests

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative split $77.7 million among 12 new contract awards…

6 days ago

FDA session to address COVID-19 oral treatment

Food and Drug Administration (FDA) officials said the agency will conduct a Nov. 30 meeting via its Antimicrobial Drugs Advisory…

6 days ago

REGEN-COV earns FDA priority review and EMA review for use against COVID-19

Following two successful Phase 3 trials of more than 6,000 patients, the United States Food and Drug Administration (FDA) last…

6 days ago

MITRE panel: Maintain warp speed in preparation for next global health crisis

The all-star team of government officials, scientists and industry executives who tackled COVID-19 made great strides in the development of…

1 week ago

Emergent BioSolutions begins phase 3 study of chikungunya virus vaccine candidate

The first participant in a new trial phase recently received a dose of a vaccine candidate against chikungunya disease that…

1 week ago

20 years after anthrax attacks, report finds U.S. government still behind on biodetection

Shortly after the terrorist events of Sept. 11, 2001, letters containing deadly anthrax spores arrived at locations across the country,…

1 week ago

Smiths Detection details emerging variants identification efforts

The threat detection and security screening technology firm Smiths Detection recently confirmed its BioFlash air sampler detects a series of…

1 week ago

Lawmakers urge expanded global COVID-19 vaccine access, review of Moderna-HHS contract

In a letter to high-ranking members of the Biden Administration’s COVID-19 response efforts, three Democratic senators and representatives this week…

1 week ago

COVAX to purchase 176.5 million doses of Moderna COVID-19 vaccine in 2022

Through exercise of an option with Moderna, Inc., Gavi, the Vaccine Alliance will purchase another 176.5 million doses of the…

1 week ago

CARB-X pursuit of antibiotic resistant bacteria countermeasures reach 95 projects in fifth year

According to the latest annual report from the global nonprofit partnership CARB-X, at the close of its fifth fiscal year…

1 week ago

Moderna initiates Africa-based mRNA facility

Moderna officials said the company is slated to build a messenger RNA (mRNA) facility in Africa, producing up to 500…

2 weeks ago

BARDA to support Phase 3 trial of treatment for C. difficile bacterial infections

VE303, an oral treatment developed by Vedanta Biosciences for patients at high risk of recurrent C. difficile infections (CDI), will…

2 weeks ago

WHO approves world’s first malaria vaccine for children

The World Health Organization (WHO) has recommended the first vaccine to treat malaria in children, a mosquito-borne disease that kills…

2 weeks ago

AstraZeneca requests FDA emergency use authorization for long-acting COVID-19 antibody combination

Although its COVID-19 vaccine was never authorized for use in the United States, AstraZeneca submitted a request with the U.S.…

2 weeks ago

Johnson & Johnson requests FDA emergency use authorization for COVID-19 booster vaccine

Ending speculation, Johnson & Johnson (J&J) this week officially submitted data to the United States Food and Drug Administration (FDA)…

2 weeks ago

FDA approves over-the-counter COVID-19 home test

The over-the-counter (OTC) ACON Laboratories Flowflex COVID-19 Home Test has received Food and Drug Administration (FDA) emergency use authorization. FDA…

3 weeks ago

Bipartisan Commission on Biodefense warns of biological threats to critical U.S. infrastructure

In a new report issued this week, the Bipartisan Commission on Biodefense warned that the United States needs to protect…

3 weeks ago

Report shows reduction in COVID-19 hospitalizations and deaths among users of Merck antiviral

Results of an interim analysis for the Phase 3 trial of molnupiravir, an investigational oral antiviral for COVID-19 produced by…

3 weeks ago

Phase 3 trial for Regeneron COVID-19 treatment shows 70 percent reductions in hospitalization or death

Safe and effective: this was the verdict of Phase 3 trial results for Regeneron Pharmaceuticals, Inc.’s REGEN-COV COVID-19 treatment, as…

3 weeks ago

BARDA, Clarivate partner on therapeutics to treat chlorine and sulfur mustard injuries

An ages-old issue may be on the road to modern solutions, thanks to a new collaboration between the Biomedical Advanced…

3 weeks ago

Raytheon, Northrop Grumman tout hypersonic weapon test

Raytheon Missiles & Defense and Northrop Grumman personnel are touting the successful completion of the first flight test of a…

4 weeks ago

Nuclear Threat Initiative gathered 100 experts to address global biosecurity

Earlier this month, the Nuclear Threat Initiative gathered 100 international experts on biosafety for the 2021 Virtual Global Biosecurity Dialogue…

4 weeks ago

WHO endorses Regeneron drug as COVID-19 countermeasure, but calls for lower prices

The World Health Organization (WHO) approved Regeneron Pharmaceuticals’ drug cocktail of casirivimab and imdevimab for use on COVID-19 patients last week,…

4 weeks ago

Global leaders reiterate efforts to ensure equitable COVID-19 vaccines access worldwide

At the United States-hosted Global COVID-19 Summit last week, world leaders recommitted to guaranteeing equitable vaccine access for all countries…

4 weeks ago

IAEA and PREZODE to collaborate in fight against zoonotic diseases

A cooperative effort was enacted against zoonotic diseases this week, with an agreement reached between the International Atomic Energy Agency…

1 month ago

Curtiss-Wright secures $100 million Navy pact

Curtiss-Wright Corporation officials said the firm has secured Navy contracts totaling $100 million to provide pumps for the military branch's…

1 month ago

INOVIO approved to begin Phase 3 efficacy trial of COVID-19 vaccine candidate in Mexico

The Mexican government approved biotechnology company INOVIO to begin a Phase 3 efficacy trial of its COVID-19 DNA vaccine candidate,…

1 month ago

IDSA, HIVSA call for U.S. leadership in global vaccine equity

The Infectious Diseases Society of America (IDSA) and its HIV Medicine Association (HIVMA) announced that it supports the Biden Administration’s…

1 month ago

FDA authorizes emergency use of Pfizer-BioNTech booster COVID-19 vaccines for vulnerable populations

While falling short of the full authorization Pfizer Inc. and BioNTech SE have clamored for, the United States Food and…

1 month ago

NTI commends Biden for hosting global COVID-19 summit

The Nuclear Threat Initiative (NTI) commended President Joe Biden for hosting a Global COVID-19 Summit and encouraged those participating in…

1 month ago

US, Pfizer and BioNTech agree to provide extra 500 million COVID-19 vaccine doses to developing world

Tacking onto President Joe Biden’s call to make the United States an arsenal of vaccines for the world, Pfizer Inc.…

1 month ago

Manufacturers push for PPE made in the U.S. amid changing legal landscape, Chinese industry dominance

As the CEO of American PAPR, a Brooklyn-based company that manufactures American-made personal protective equipment, Giles Kyser has hired lobbyists…

1 month ago

This website uses cookies.